Long-Term Use of Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Graft-versus-Host Disease
Open Access
- 31 August 2005
- journal article
- clinical trial
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 11 (8), 587-592
- https://doi.org/10.1016/j.bbmt.2005.04.008
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Budesonide: A novel treatment for oral chronic graft versus host diseaseOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2003
- PERSISTENT NAUSEA AND ANOREXIA AFTER MARROW TRANSPLANTATIONTransplantation, 1998
- Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: A randomized, controlled trialGastroenterology, 1998
- ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF HUMAN INTESTINAL GRAFT-VERSUS-HOST DISEASETransplantation, 1995
- Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 1993
- A retrospective analysis of therapy for acute graft-versus-host disease: initial treatmentBlood, 1990
- Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapyBlood, 1990
- Diffuse intestinal ulceration after marrow transplantation: A clinicopathologic study of 13 patientsHuman Pathology, 1986
- Beclomethasone Dipropionate InhalerDrugs, 1975
- Absorption and metabolism of orally administered beclomethasone dipropionateClinical Pharmacology & Therapeutics, 1974